advertisement
Cancers 7
Showing records 1 to 7 | Display all abstracts in Cancers99226 Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
Fastner G
Cancers 2022; 14:
98822 The Incidence Risk for Primary Glaucoma and Its Subtypes following Chronic Exposure to Ionizing Radiation in the Russian Cohort of Mayak Nuclear Workers
Azizova TV; Bragin EV
Cancers 2022; 14:
99226 Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
Reitsamer R; Gaisberger C
Cancers 2022; 14:
98822 The Incidence Risk for Primary Glaucoma and Its Subtypes following Chronic Exposure to Ionizing Radiation in the Russian Cohort of Mayak Nuclear Workers
Bannikova MV
Cancers 2022; 14:
99226 Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
Hitzl W
Cancers 2022; 14:
98822 The Incidence Risk for Primary Glaucoma and Its Subtypes following Chronic Exposure to Ionizing Radiation in the Russian Cohort of Mayak Nuclear Workers
Hamada N; Grigoryeva ES
Cancers 2022; 14:
99226 Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
Urbański B; Murawa D; Matuschek C; Budach W; Ciabattoni A; Reiland J; Molnar M; Vidali C; Schumacher C; Sedlmayer F; On Behalf Of The Hiob Trialist Group
Cancers 2022; 14:
